The association between the length of the QT interval and mortality in the cardiovascular health study

American Journal of Medicine

Volumn 115, Issue 9, 2003, Pages 689-694

  Robbins, John ^a,e   Nelson, Jennifer Clark ^b   Rautaharju, Pentti M ^c   Gottdiener, John S ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c WAKE FOREST UNIVERSITY   (United States)

^d ST FRANCIS HOSPITAL   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM; COMMUNITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; HEALTH STATUS; HIGH RISK PATIENT; HUMAN; ISCHEMIC HEART DISEASE; MALE; MORTALITY; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; RISK FACTOR;

EID: 0347418230     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2003.07.014     Document Type: Article

References (26)

1. Bednar M.M., Harrigan E.P., Anziano R.J., et al. The QT interval. Prog Cardiovasc Dis. 43 (suppl 1):2001;1-45.
2. Schouten E.G., Dekker J.M., Meppelink P., et al. QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation. 84:1991;1516-1523.
3. Dekker J.M., Schouten E.G., Klootwijk P., et al. Association between QT interval and coronary heart disease in middle-aged and elderly men. The Zutphen Study. Circulation. 90:1994;779-785.
4. de Bruyne M.C., Hoes A.W., Kors J.A., et al. Prolonged QT interval predicts cardiac and all-cause mortality in the elderly. The Rotterdam Study. Eur Heart J. 20:1999;278-284.
5. Karjalainen J., Reunanen A., Rustika P., et al. Interval as a cardiac risk factor in a middle aged population. Heart. 77:1997;543-548.
6. Festa A., D'Agostino R. Jr, Rautaharju P., et al. Is QT interval a marker of subclinical atherosclerosis in nondiabetic subjects? The Insulin Resistance Atherosclerosis Study (IRAS). Stroke. 30:1999;1566-1571.
7. Festa A., D'Agostino R. Jr, Rautaharju P., et al. Relation of systemic blood pressure, left ventricular mass, insulin sensitivity, and coronary artery disease to QT interval duration in nondiabetic and type 2 diabetic subjects. Am J Cardiol. 86:2000;1117-1122.
8. Sawicki P.T., Dahne R., Bender R., Berger M. Prolonged QT interval as a predictor of mortality in diabetic nephropathy. Diabetologia. 39:1996;77-81.
9. Goldberg R.J., Bengtson J., Chen Z.Y., et al. Duration of the QT interval and total and cardiovascular mortality in healthy persons (The Framingham Heart Study experience). Am J Cardiol. 67:1991;55-58.
10. Rautaharju P.M., Manolio T.A., Psaty B.M., et al. Correlates of QT prolongation in older adults. Am J Cardiol. 73:1994;999-1002.
11. Fried L.P., Borhani N.O., Enright P., et al. The Cardiovascular Health Study design and rationale . Ann Epidemiol. 1:1991;263-279.
12. Bazett H.C. An analysis of the time-relations of electrocardiograms. Heart. 7:1920;35-70.
13. Rautaharju P.M., Warren J.W., Calhoun H.P. Estimation of QT prolongation. A persistent, avoidable error in computer electrocardiography. J Electrocardiol. 23(suppl):1992;111-118.
14. Rautaharju P.M., Zhang Z.M. Linearly scaled, rate-invariant normal limits for QT interval. Eight decades of incorrect application of power functions. J Cardiovasc Electrophysiol. 13:2002;1211-1218.
15. Psaty B.M., Furberg C.D., Kuller L.H., et al. Isolated systolic hypertension and subclinical cardiovascular disease in the elderly initial findings from the Cardiovascular Health Study . JAMA. 268:1992;1287-1291.
16. Furberg C.D., Manolio T.A., Psaty B.M., et al. Major electrocardiographic abnormalities in persons aged 65 years and older the Cardiovascular Health Study . Am J Cardiol. 69:1992;1329-1335.
17. O'Leary D.H., Polak J.F., Wolfson S.K. Jr, et al. Use of sonography to evaluate carotid atherosclerosis in the elderly the Cardiovascular Health Study . Stroke. 22:1991;1155-1163.
18. Psaty B.M., Kuller L.H., Bild D., et al. Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. Ann Epidemiol. 5:1995;270-277.
19. Ives D.G., Fitzpatrick A.L., Bild D.E., et al. Surveillance and ascertainment of cardiovascular events the Cardiovascular Health Study . Ann Epidemiol. 5:1995;278-285.
20. Hinkle L.E. Jr, Thaler H.T. Clinical classification of cardiac deaths. Circulation. 65:1982;457-464.
21. Drug Facts and Comparisons. Philadelphia, Pennsylvania: J. B. Lippincott Co.; 1990:537.
22. Ahnve S., Gilpin E., Madsen E.B., et al. Prognostic importance of QTc interval at discharge after acute myocardial infarction a multicenter study of 865 patients . Am Heart J. 108:1984;395-400.
23. Algra A., Tijssen J.G.P., Roelandt J.R., et al. QT interval variables from 24 hour electrocardiography and the two year risk of sudden death. Br Heart J. 70:1993;43-48.
24. Moss A.J. The QT interval and torsade de pointes. Drug Safety. 21suppl:1999;5-10.
25. Coumel P., Maison-Blanche P., Badilini F. Dispersion of ventricular repolarization: reality? Illusion? Significance? Circulation. 97:1998;2491-2493.
26. Rautaharju P.M. What killed QT dispersion? Card Electrophysiol Rev. 6:2002;295-301.